Related Experiment Video
Updated: Jan 24, 2026
09:29
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
18.8K
Pericytes in Breast Cancer.
1Department of Biological Sciences, North Dakota State University, Fargo, ND, USA. jiha.kim.1@ndsu.edu.
Advances in Experimental Medicine and Biology
|June 1, 2019
Summary
Breast cancer is complex, involving diverse cells and a dynamic microenvironment. Understanding pericyte heterogeneity is crucial for developing new breast cancer treatments by revealing their roles in progression and metastasis.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Breast cancer is a heterogeneous disease influenced by cancer cells and the tumor microenvironment.
- Tumor vasculature, critical for growth and metastasis, exhibits abnormalities like perfusion defects, dilation, and tortuosity in breast cancer.
- Pericytes, crucial for vessel stability, show significant heterogeneity and altered functions in breast cancer, impacting tumor progression.
Purpose of the Study:
- To investigate the largely unknown impact of pericyte heterogeneity on breast cancer progression, metastasis, intratumoral immunity, and chemotherapy response.
- To explore the complex interactions within the tumor microenvironment, focusing on pericyte contributions.
- To identify potential new therapeutic strategies by understanding pericyte heterogeneity in breast cancer.
Main Methods:
- Analysis of pericyte populations and their heterogeneity within the breast cancer microenvironment.
- Investigation of pericyte roles in tumor vascularization, progression, and metastasis.
- Examination of the influence of pericyte heterogeneity on intratumoral immunity and response to therapy.
Main Results:
- Pericyte heterogeneity significantly influences breast cancer progression and metastasis.
- Altered pericyte populations contribute to abnormal tumor vasculature and affect intratumoral immunity.
- The functional diversity of pericytes presents challenges and opportunities for targeted breast cancer therapies.
Conclusions:
- Pericyte heterogeneity is a key factor in breast cancer development and progression.
- Targeting specific pericyte subpopulations may offer novel therapeutic avenues for breast cancer.
- Further research into pericyte-stromal cell interactions is essential for advancing breast cancer treatment.
Related Concept Videos
02:18Cancer
53.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.8K
02:12What is Cancer?
14.1K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.1K
02:59Cancer Prevention
7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.7K
02:49Cancer Therapies
9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
01:30Cancer Vaccines
989
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
989
01:30Skin Cancer
5.8K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.8K